NewsMarkets

Health

Optogenetics Trial Shows Early Promise for Restoring Vision in Blindness Patients

A small study finds that genetically engineered optogenetic treatment restores light sensitivity to some patients with advanced retinitis pigmentosa.

2 publishers · 2 articles · first seen 7 Oct 2026 · updated 2h ago

The story so far

2 publishers have covered this in 2 articles since 7 Oct 2026. STAT published first, on 7 October at 21:00 UTC; MedPageToday.com - medical news for physicians followed 18h 54m later. The most recent article, from MedPageToday.com - medical news for physicians, appeared on 8 October at 15:53 UTC.

Outlets reporting it: STAT, MedPageToday.com - medical news for physicians.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Genetically Engineered Treatment for Blindness Shows Early Promise in Small Study MedPageToday.com - medical news for physicians
  2. STAT+: In small trial, optogenetics restores some vision lost to retinitis pigmentosa STAT
Embed this story

Paste this into any web page to show the live odds, with a link back here.